Mark Weiser

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Placebo Controlled

Top Venues

Molecular psychiatry

Translational psychiatry

Bipolar disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Amanda Worker, Pierre Berthert, Andrew J Lawrence, Seyed Mostafa Kia, Celso Arango, Richard Dinga, Silvana Galderisi, Birte Yding Glenthøj, Rene S Kahn, Anoushka Leslie, Robin M Murray, Carmine Maria Pariante, Christos Pantelis, Mark Weiser, Inge Winter-van Rossum, Philip McGuire, Paola Dazzan, Andre F Marquand
Extreme deviations from the normative model reveal cortical heterogeneity and associations with negative symptom severity in first-episode psychosis from the OPTiMiSE and GAP studies. Translational psychiatry 13 (1) (2023)
Nehama Frimit Goldberger, Tal Bergman-Levy, Ziona Haklai, Rinat Yoffe, Michael Davidson, Ehud Susser, Linda Levi, Tal Elhasid, Mark Weiser
COVID-19 and severe mental illness in Israel: testing, infection, hospitalization, mortality and vaccination rates in a countrywide study. Molecular psychiatry 27 (7) (2022)
Mark Weiser, Michael Davidson
Identifying an elusive target with the help of an unproven technique. Molecular psychiatry (2021)
Mark Weiser, Linda Levi, Stephen Z Levine, Meir Bialer, Tawfeeq Shekh-Ahmad, Valentin Matei, Alexandru Tiugan, Diana Cirjaliu, Cristinel Sava, Eugenia Sinita, Daisy Zamora, John M Davis
A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania. Bipolar disorders 19 (4) (2017)